Uncategorised - European Medical Journal

Continue
EMJ
10 Jul 2015

CheckMate 067: Phase 3 trial of nivolumab in melanoma

University of Nebraska Medical Center, Omaha, NE, discusses the phase 3 CheckMate 067 trial of nivolumab alone or combined with ipilimumab versus…
EMJ
10 Jul 2015

COMBI-d: Phase 3 trial of dabrafenib plus trametinib in BRAF V600E/K-mutated melanoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney…
EMJ
10 Jul 2015

Phase 3 trial of whole brain radiation therapy in addition to radiosurgery for brain metastases

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Andrew B. Lassman, MD, of Columbia University Medical Center, New York, NY…
EMJ
10 Jul 2015

The treatment landscape of metastatic kidney cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, James Larkin, FRCP, PhD, of The Royal Marsden, London, UK, provides an overview…
EMJ
10 Jul 2015

Phase 3 trial of eribulin versus dacarbazine in leiomyosarcoma and liposarcoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Patrick Schöffski, MD, of University Hospitals Leuven, Leuven, Belgium…
EMJ
10 Jul 2015

Phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, James Larkin, FRCP, PhD, of The Royal Marsden, London, UK, discusses the results…
EMJ
10 Jul 2015

TATTON: Phase 1b trial of combination therapies with AZD9291 in EGFR-mutant lung cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Geoffrey R. Oxnard, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses…
7 Jul 2015

Treatment of Secondary Mitral Regurgitation via Percutaneous Annuloplasty

Functional mitral regurgitation (FMR) is a common occurrence in patients with heart failure (HF). FMR is associated with as much as a 2-fold increase in…
EMJ
6 Jul 2015

AndraTec Optimus & Optimus Covered XL Stents a Novel Technology Stent Device

In the daily practise of an interventional paediatric cardiologist we often miss adequate material to treat complex lesions in vessel stenosis.
EMJ
6 Jul 2015

Second-Line Cetuximab Active beyond Progression in Quadruple Wild-Type Patients with Metastatic Colorectal Cancer

BARCELONA-LUGANO, 4 July 2015 – Patients with metastatic colorectal cancer (mCRC) that are mutation-free in the KRAS, NRAS, BRAF and PIK3CA genes…